Analysts Set Plexus Corp. (NASDAQ:PLXS) Price Target at $125.25

Shares of Plexus Corp. (NASDAQ:PLXS) have earned a consensus rating of “Hold” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $129.75.

A number of equities research analysts have issued reports on PLXS shares. Needham & Company LLC upped their price objective on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research report on Friday. Benchmark restated a “buy” rating and set a $150.00 price objective on shares of Plexus in a research report on Monday, October 21st. Finally, KeyCorp assumed coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating on the stock.

Plexus Price Performance

Shares of Plexus stock opened at $141.19 on Tuesday. The stock has a 50 day moving average of $130.82 and a 200 day moving average of $116.26. Plexus has a 12 month low of $88.57 and a 12 month high of $153.60. The firm has a market cap of $3.84 billion, a PE ratio of 35.56 and a beta of 0.89. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The company had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the prior year, the company earned $1.44 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. On average, research analysts expect that Plexus will post 3.74 EPS for the current fiscal year.

Insider Buying and Selling at Plexus

In other news, insider Steven J. Frisch sold 6,565 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total value of $841,042.15. Following the completion of the sale, the insider now owns 36,118 shares of the company’s stock, valued at $4,627,076.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Steven J. Frisch sold 6,565 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total value of $841,042.15. Following the completion of the transaction, the insider now owns 36,118 shares in the company, valued at $4,627,076.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Todd P. Kelsey sold 3,000 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.40, for a total value of $385,200.00. Following the completion of the transaction, the chief executive officer now owns 93,682 shares of the company’s stock, valued at $12,028,768.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,113 shares of company stock valued at $2,541,394. 2.39% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Plexus

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PLXS. Quest Partners LLC raised its stake in Plexus by 36,700.0% in the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after acquiring an additional 367 shares during the last quarter. Innealta Capital LLC purchased a new position in shares of Plexus during the 2nd quarter valued at about $51,000. EntryPoint Capital LLC raised its stake in shares of Plexus by 56.2% during the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after buying an additional 351 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Plexus by 190.1% during the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after buying an additional 498 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of Plexus by 12.0% during the 2nd quarter. Signaturefd LLC now owns 1,705 shares of the technology company’s stock valued at $176,000 after buying an additional 183 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.